- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03338751
Determine the Effect on Cognitive Impairment Measures by Providing Hearing-Assistance to Skilled Nursing Facility Residents (DECIPHER)
The purpose of the study is to see if a commercially available hearing assistance device called the PockeTalker has an effect on performance on cognitive (memory and thinking) tests among skilled nursing facility residents.
Investigators are asking residents to perform cognitive tests with and without hearing assistance equipment known as PockeTalkers. This study will be conducted at one urban Skilled Nursing Facility (SNF) with the goal of understanding the extent to which hearing impairment impacts commonly used cognitive impairment measures for clinical assessment. Cognitive performance will be measured, cerumen occlusion, and perceived hearing.
Study Overview
Status
Conditions
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- New York University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- admitted to unit of intervention
- ability to communicate and follow simple commands
- capacity to consent assessed with standard questions used to assess capacity or having a surrogate who can provide consent.
Exclusion Criteria:
- not on the unit of intervention
- obtunded or comatose state
- inability to communicate verbally
- inability to consent and without surrogate
- non-English speaking
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Hearing Assistance Device (HAD) First
Tablet, loaded with REDCap will generate a random number that determines the order of test administration with the HAD first or second.
Participants randomized to HAD first will use a Hearing Aid Device.
|
tablet, loaded with REDCap will generate a random number that determines the order of test administration with the HAD first or second.
Other Names:
tablet, loaded with REDCap will generate a random number that determines the order of test administration with the HAD first or second.
|
|
ACTIVE_COMPARATOR: No Hearing Assistance Device (HAD) First
Sham hearing aid device
|
tablet, loaded with REDCap will generate a random number that determines the order of test administration with the HAD first or second.
Other Names:
tablet, loaded with REDCap will generate a random number that determines the order of test administration with the HAD first or second.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measure of Cognitive function using Mini-Cog
Time Frame: 20 Minutes
|
three-item recall and a clock draw test.
24 Medical assistants have been trained and have employed this test successfully in primary care practices.
The Mini-Cog has test characteristics that are comparable to any other brief instrument and exceeds most in accuracy or predictive quality.
|
20 Minutes
|
|
Perceived Hearing measured by Hearing Handicap Inventory for the Elderly-Screening Version (HHIE)
Time Frame: 20 Minutes
|
HHIE-S is a valid, robust test for identifying hearing-impaired elderly, irrespective of the audiometric definition used to finally diagnose hearing difficulties.
|
20 Minutes
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-00697
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Impairment
-
University of North Carolina, Chapel HillMed-El CorporationCompletedHigh Frequency Sensorineural Hearing Impairment | Hearing Disorders in ChildrenUnited States
-
Washington University School of MedicineNational Institute on Aging (NIA)CompletedHearing Impairment, SensorineuralUnited States
-
University of Southern DenmarkInnovation Fund Denmark; William Demant FondenRecruitingHearing Loss, Sensorineural | Hearing Impairment, SensorineuralDenmark
-
CochlearTerminatedHearing Impairment, SensorineuralArgentina
-
Oticon MedicalCompletedHearing Impairment, Conductive | Deafness Unilateral | Hearing Impaired (Partially)Denmark
-
CochlearAvaniaCompletedHearing Impairment, SensorineuralAustralia
-
University Hospital Inselspital, BerneCochlear; Stiftung Besser HörenTerminatedHearing-ImpairmentSwitzerland
-
King Saud UniversityRecruitingNutrition, Healthy | Profound Hearing ImpairmentSaudi Arabia
-
University College, LondonCompletedFrequency Compression | Severe-profound Hearing Impairment
Clinical Trials on cognitive testing with HAD (PockeTalker) First
-
University of Michigan Rogel Cancer CenterTerminated
-
San Francisco Department of Public HealthCenters for Disease Control and PreventionCompletedHIV Infections | Episodic Substance UseUnited States
-
University of ArkansasArkansas Children's Hospital Research InstituteCompleted
-
Philipps University Marburg Medical CenterPsychotherapie-Ambulanz Marburg e.V.CompletedTemporomandibular DisordersGermany
-
Clea TuckerRecruitingMild Traumatic Brain InjuryUnited States
-
Leiden University Medical CenterSanquin-LUMC J.J van Rood Center for Clinical Transfusion ResearchUnknownNeurodevelopmental Abnormality | Fetal and Neonatal Alloimmune Thrombocytopenia | Long Term Adverse Effects | Intravenous Immunoglobulin Adverse ReactionNetherlands
-
Oncovir, Inc.Chevy Chase Healthcare, Chevy Chase MD; Mt. Sinai School of Medicine, New York... and other collaboratorsTerminated
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingQuality of Life | Hodgkin Lymphoma | Non Hodgkin Lymphoma | Stage I Breast Cancer | Stage II Breast Cancer | Stage III Breast Cancer | Heart; Functional DisturbanceUnited States
-
Centre for Addiction and Mental HealthNational Institute on Drug Abuse (NIDA)CompletedCannabis DependenceCanada